Anavex Life Sciences Corp (AVXL)

[Steady_T]

As of 2022 10K accumulated deficit was $245,563,781.

With Missling, there is no predicting what he will do with the voucher.

It hits the books as an asset with about $100,000,000 value. He may want to use that asset value to help secure additional financing. He has said that as soon as possible he wants to use conventional bank financing going forward. Having that on the books should help secure a much better loan rate as it would be tangible collateral. At this point the company doesn't have much in assets other than Intellectual Property. A bank valuing 2-73 as a drug will have to be done once it is approved and generating an actual revenue stream. As we saw with the mabs recently approved, getting the drug on the market doesn't always translate into a big revenue stream and the banks know that.